Research output per year
Research output per year
Personal profile
Research interests
Dr. Zolkind's research focuses on utilizing a bench-to-bedside approach for developing novel techniques to treat head and neck cancer. I am working to better understand the molecular pathways that drive tumorigenesis and metastasis and identify how the interactions between the immune system and tumor cells can be harnessed through novel and combination immunotherapies to better treat cancer patients.
Clinical interests
My clinical interest is head and neck surgical oncology and microvascular reconstruction. This includes: benign and malignant tumors, thyroid and parathyroid tumors, salivary gland disorders, head and neck cutaneous malignancy, parapharyngeal space tumors, and reconstruction of head and neck defects.
Fingerprint
Dive into the research topics where Paul Zolkind is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinoma
Yan, E. Z., Wahle, B. M., Massa, S. T., Zolkind, P., Paniello, R. C., Pipkorn, P., Jackson, R. S., Rich, J. T., Puram, S. V. & Mazul, A. L., Apr 2023, In: Cancer medicine. 12, 8, p. 9976-9987 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders
Zhou, L., Zeng, Z., Egloff, A. M., Zhang, F., Guo, F., Campbell, K. M., Du, P., Fu, J., Zolkind, P., Ma, X., Zhang, Z., Zhang, Y., Wang, X., Gu, S., Riley, R., Nakahori, Y., Keegan, J., Haddad, R., Schoenfeld, J. D., Griffith, O., & 4 others, Jan 20 2022, In: Journal for ImmunoTherapy of Cancer. 10, 1, e004034.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Integrative genomic analysis reveals low T-cell infiltration as the primary feature of tobacco use in HPV-positive oropharyngeal cancer
Wahle, B. M., Zolkind, P., Ramirez, R. J., Skidmore, Z. L., Anderson, S. R., Mazul, A., Hayes, D. N., Sandulache, V. C., Thorstad, W. L., Adkins, D., Griffith, O. L., Griffith, M. & Zevallos, J. P., May 20 2022, In: iScience. 25, 5, 104216.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Erratum: Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus⇓unrelated head and neck cancer: A multicenter, phase II trial (CLINICAL CANCER RESEARCH2020;26:5140–52 DOI: 10.1158/1078-0432.CCR-20-1695)
Uppaluri, R., Campbell, K. M., Egloff, A. M., Zolkind, P., Skidmore, Z. L., Nussenbaum, B., Paniello, R. C., Rich, J. T., Jackson, R., Pipkorn, P., Michel, L. S., Ley, J., Oppelt, P., Dunn, G. P., Barnell, E. K., Spies, N. C., Lin, T., Li, T., Mulder, D. T., Hanna, Y., & 24 others, Jan 1 2021, In: Clinical Cancer Research. 27, 1, p. 357 1 p.Research output: Contribution to journal › Comment/debate
Open Access3 Scopus citations -
Integrating CD4+ T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model
Shibata, H., Xu, N., Saito, S., Zhou, L., Ozgenc, I., Webb, J., Fu, C., Zolkind, P., Egloff, A. M. & Uppaluri, R., 2021, In: OncoImmunology. 10, 1, 1958589.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations